Andreas Schaaf

625 total citations
22 papers, 412 citations indexed

About

Andreas Schaaf is a scholar working on Molecular Biology, Organic Chemistry and Biotechnology. According to data from OpenAlex, Andreas Schaaf has authored 22 papers receiving a total of 412 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Organic Chemistry and 6 papers in Biotechnology. Recurrent topics in Andreas Schaaf's work include Transgenic Plants and Applications (6 papers), Lysosomal Storage Disorders Research (5 papers) and Carbohydrate Chemistry and Synthesis (5 papers). Andreas Schaaf is often cited by papers focused on Transgenic Plants and Applications (6 papers), Lysosomal Storage Disorders Research (5 papers) and Carbohydrate Chemistry and Synthesis (5 papers). Andreas Schaaf collaborates with scholars based in Germany, Hungary and United States. Andreas Schaaf's co-authors include Ralf Reski, Eva L. Decker, Andreas Büsch, Thomas Frischmuth, Peter F. Zipfel, Benjamin Fode, Juliana Parsons, Andreas Schlösser, Paulina Dabrowska‐Schlepp and Andrea Hartmann and has published in prestigious journals such as International Journal of Molecular Sciences, Journal of the American Society of Nephrology and Frontiers in Immunology.

In The Last Decade

Andreas Schaaf

19 papers receiving 395 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andreas Schaaf Germany 10 230 125 104 95 85 22 412
Juliana Parsons Germany 13 356 1.5× 250 2.0× 168 1.6× 24 0.3× 90 1.1× 20 493
Pascal Martinez France 12 504 2.2× 47 0.4× 17 0.2× 22 0.2× 118 1.4× 14 605
Qingchun Zhou China 16 272 1.2× 121 1.0× 55 0.5× 11 0.1× 89 1.0× 44 566
Sebastian N. W. Hoernstein Germany 13 283 1.2× 67 0.5× 56 0.5× 9 0.1× 125 1.5× 26 362
Shean‐Tai Chiou United States 9 321 1.4× 25 0.2× 44 0.4× 13 0.1× 269 3.2× 9 573
Yuki Tsunoda Japan 8 239 1.0× 13 0.1× 76 0.7× 13 0.1× 67 0.8× 15 315
Debabrata Laha Germany 12 252 1.1× 17 0.1× 13 0.1× 19 0.2× 426 5.0× 23 628
Gilbert Gorr Germany 17 719 3.1× 493 3.9× 218 2.1× 34 0.4× 284 3.3× 24 920
Catherine Alonso France 11 289 1.3× 22 0.2× 90 0.9× 84 0.9× 57 0.7× 13 378
Hongjuan Gao China 11 227 1.0× 25 0.2× 153 1.5× 14 0.1× 42 0.5× 22 415

Countries citing papers authored by Andreas Schaaf

Since Specialization
Citations

This map shows the geographic impact of Andreas Schaaf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Schaaf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Schaaf more than expected).

Fields of papers citing papers by Andreas Schaaf

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas Schaaf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Schaaf. The network helps show where Andreas Schaaf may publish in the future.

Co-authorship network of co-authors of Andreas Schaaf

This figure shows the co-authorship network connecting the top 25 collaborators of Andreas Schaaf. A scholar is included among the top collaborators of Andreas Schaaf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas Schaaf. Andreas Schaaf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dabrowska‐Schlepp, Paulina, et al.. (2025). Moss-derived human complement factor H modulates retinal immune response and attenuates retinal degeneration. Journal of Neuroinflammation. 22(1). 104–104. 1 indexed citations
2.
Fode, Benjamin, et al.. (2025). Engineering the moss Physcomitrium patens to produce proteins with paucimannosidic glycans. Frontiers in Plant Science. 16. 1605548–1605548.
3.
Dabrowska‐Schlepp, Paulina, Karsten Häffner, Anne Wolf, et al.. (2025). Moss-produced complement factor H (CPV-104) as a therapeutic regulator in complement-mediated diseases. Immunobiology. 230(4). 152989–152989.
4.
Dabrowska‐Schlepp, Paulina, Andreas Büsch, Andreas Schaaf, et al.. (2025). Effective long-term treatment with moss-produced factor H by overcoming the antibody response in a mouse model of C3G. Frontiers in Immunology. 16. 1535547–1535547. 1 indexed citations
5.
Büsch, Andreas, Andrea Hartmann, Marina Noris, et al.. (2024). Moss-produced human complement factor H with modified glycans has an extended half-life and improved biological activity. Frontiers in Immunology. 15. 1383123–1383123. 5 indexed citations
6.
Dabrowska‐Schlepp, Paulina, Andreas Büsch, Jin‐Song Shen, et al.. (2023). Comparison of efficacy between subcutaneous and intravenous application of moss‐aGal in the mouse model of Fabry disease. JIMD Reports. 64(6). 460–467. 3 indexed citations
7.
Hintze, Stefan, Paulina Dabrowska‐Schlepp, Andreas Büsch, et al.. (2021). Uptake of moss‐derived human recombinant GAA in Gaa−/− mice. JIMD Reports. 59(1). 81–89. 4 indexed citations
8.
Hintze, Stefan, Paulina Dabrowska‐Schlepp, Andreas Büsch, et al.. (2020). Moss-Derived Human Recombinant GAA Provides an Optimized Enzyme Uptake in Differentiated Human Muscle Cells of Pompe Disease. International Journal of Molecular Sciences. 21(7). 2642–2642. 13 indexed citations
9.
Hennermann, Julia B., et al.. (2019). Pharmacokinetics, pharmacodynamics, and safety of moss‐aGalactosidase A in patients with Fabry disease. Journal of Inherited Metabolic Disease. 42(3). 527–533. 42 indexed citations
10.
Hennermann, Julia B., et al.. (2018). Pharmacokinetics, pharmacodynamics, and safety of moss agalactosidase A in patients with Fabry disease. Molecular Genetics and Metabolism. 123(2). S61–S62. 1 indexed citations
11.
Häffner, Karsten, Juliana Parsons, Sebastian N. W. Hoernstein, et al.. (2017). Treatment of experimental C3 Glomerulopathy by human complement factor H produced in glycosylation-optimized Physcomitrella patens. Molecular Immunology. 89. 120–120. 4 indexed citations
12.
Michelfelder, Stefan, Juliana Parsons, Sebastian N. W. Hoernstein, et al.. (2016). Moss-Produced, Glycosylation-Optimized Human Factor H for Therapeutic Application in Complement Disorders. Journal of the American Society of Nephrology. 28(5). 1462–1474. 38 indexed citations
13.
Shen, Jin‐Song, Andreas Büsch, Xing‐Li Meng, et al.. (2015). Mannose receptor‐mediated delivery of moss‐made α‐galactosidase A efficiently corrects enzyme deficiency in Fabry mice. Journal of Inherited Metabolic Disease. 39(2). 293–303. 74 indexed citations
14.
Parsons, Juliana, H. Kim Jerome, Andrea Hartmann, et al.. (2010). Production of biologically active recombinant human factor H in Physcomitrella. Plant Biotechnology Journal. 9(3). 373–383. 73 indexed citations
15.
Stumpe, Michael, Julia Bode, Claus Göbel, et al.. (2006). Biosynthesis of C9-aldehydes in the moss Physcomitrella patens☆. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1761(3). 301–312. 54 indexed citations
16.
Schaaf, Andreas, et al.. (2005). Use of endogenous signal sequences for transient production and efficient secretion by moss (Physcomitrella patens) cells. BMC Biotechnology. 5(1). 30–30. 33 indexed citations
17.
Schaaf, Andreas, Ralf Reski, & Eva L. Decker. (2004). A novel aspartic proteinase is targeted to the secretory pathway and to the vacuole in the moss Physcomitrella patens. European Journal of Cell Biology. 83(4). 145–152. 28 indexed citations
18.
19.
Schaaf, Andreas. (1972). parasitoid complex of Euxoa ochrogaster (Guenee) (Lepidoptera: Noctuidae). Biodiversity Heritage Library (Smithsonian Institution). 16 indexed citations
20.
Schaaf, Andreas, et al.. (1963). De opbrengst van hennep bij verschillende teeltmaatregelen. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Juliana Parsons Breakdown of academic impact, for papers by Pascal Martinez Breakdown of academic impact, for papers by Qingchun Zhou Breakdown of academic impact, for papers by Sebastian N. W. Hoernstein Breakdown of academic impact, for papers by Shean‐Tai Chiou Breakdown of academic impact, for papers by Yuki Tsunoda Breakdown of academic impact, for papers by Debabrata Laha Breakdown of academic impact, for papers by Gilbert Gorr Breakdown of academic impact, for papers by Catherine Alonso Breakdown of academic impact, for papers by Hongjuan Gao
Rankless by CCL
2026